- Home
- TDW vs GLPG Comparison
TDW vs GLPG Comparison
Compare TDW & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDW
- GLPG
- Stock Information
- Founded
- TDW 1956
- GLPG 1999
- Country
- TDW United States
- GLPG Belgium
- Employees
- TDW N/A
- GLPG N/A
- Industry
- TDW Marine Transportation
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- TDW Consumer Discretionary
- GLPG Health Care
- Exchange
- TDW Nasdaq
- GLPG Nasdaq
- Market Cap
- TDW 2.4B
- GLPG 2.1B
- IPO Year
- TDW N/A
- GLPG 2005
- Fundamental
- Price
- TDW $58.72
- GLPG $31.16
- Analyst Decision
- TDW Hold
- GLPG Sell
- Analyst Count
- TDW 3
- GLPG 4
- Target Price
- TDW $68.50
- GLPG $25.33
- AVG Volume (30 Days)
- TDW 980.8K
- GLPG 270.2K
- Earning Date
- TDW 08-04-2025
- GLPG 10-29-2025
- Dividend Yield
- TDW N/A
- GLPG N/A
- EPS Growth
- TDW 26.86
- GLPG N/A
- EPS
- TDW 3.83
- GLPG N/A
- Revenue
- TDW $1,360,316,000.00
- GLPG $323,674,692.00
- Revenue This Year
- TDW $0.83
- GLPG N/A
- Revenue Next Year
- TDW $5.31
- GLPG N/A
- P/E Ratio
- TDW $15.33
- GLPG N/A
- Revenue Growth
- TDW 7.76
- GLPG 5.43
- 52 Week Low
- TDW $31.17
- GLPG $22.36
- 52 Week High
- TDW $87.35
- GLPG $33.86
- Technical
- Relative Strength Index (RSI)
- TDW 55.94
- GLPG 45.01
- Support Level
- TDW $58.91
- GLPG $31.42
- Resistance Level
- TDW $61.51
- GLPG $33.25
- Average True Range (ATR)
- TDW 2.14
- GLPG 0.76
- MACD
- TDW -0.09
- GLPG -0.18
- Stochastic Oscillator
- TDW 59.84
- GLPG 6.70
About TDW Tidewater Inc.
Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.